Progression Free Survival (IMAGE)
Caption
This graph shows progression free survival from hormone therapy in 42 endocrine-dependent metastatic breast cancer patients (by the Kaplan-Meier method); median survival time and 95 percent CI: 33, 24.4-41.6 months.
Credit
Dr. Andrea Nicolini et al., Bentham Science Publishers
Usage Restrictions
Image rights belong to Dr. Andrea Nicolini et al., Bentham Science Publishers
License
Licensed content